ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
8.09
-0.09 (-1.10%)
Apr 20, 2026, 7:07 AM EDT - Market open

ARS Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8031,1571,033528801202
Market Cap Growth
-37.26%11.93%95.59%-34.07%296.19%-87.42%
Enterprise Value
735.781,008719.4300.03527.21227.13
Last Close Price
8.0911.6510.555.488.536.66
PE Ratio
--6.70131.88-9.61-9.80-9.51
PS Ratio
9.6413.7311.5917611.80608.9236.73
PB Ratio
7.1110.124.022.292.94-6.47
P/TBV Ratio
6.9810.054.212.261.25-6.15
P/FCF Ratio
--6.7679.59-8.89-19.90-11.48
P/OCF Ratio
--6.7776.28-8.91-19.99-11.52
EV/Sales Ratio
8.7311.968.0710001.00400.6141.25
EV/EBITDA Ratio
--5.66-239.48-4.45-14.86-11.80
EV/EBIT Ratio
--5.62-233.34-4.44-14.84-11.67
EV/FCF Ratio
--5.8955.40-5.05-13.09-12.89
Debt / Equity Ratio
0.840.8400.000.000.20
Debt / EBITDA Ratio
-0.54-0.54-0.010.00-0.01-0.47
Debt / FCF Ratio
-0.56-0.570.000.00-0.01-0.51
Net Debt / Equity Ratio
-1.30-1.30-1.22-0.99-1.001.63
Net Debt / EBITDA Ratio
0.830.83104.523.387.722.65
Net Debt / FCF Ratio
0.860.87-24.183.846.802.90
Asset Turnover
0.250.250.310.000.010.02
Inventory Turnover
0.970.970.19---
Quick Ratio
6.916.9113.7595.5150.407.34
Current Ratio
7.287.2814.2696.9251.017.42
Return on Equity (ROE)
-92.33%-92.33%3.28%-21.59%-21.84%-9.47%
Return on Assets (ROA)
-52.85%-52.85%-1.04%-26.24%-20.72%-8.53%
Return on Invested Capital (ROIC)
-607.93%-607.92%-35.82%-2815.09%-17802.50%2882.07%
Return on Capital Employed (ROCE)
-58.24%-58.24%-1.10%-26.65%-21.57%-8.87%
Earnings Yield
-21.09%-14.94%0.76%-10.40%-10.20%-10.51%
FCF Yield
-21.08%-14.80%1.26%-11.25%-5.03%-8.71%
Buyback Yield / Dilution
3.74%3.74%-7.54%-138.30%-38.39%-893.01%
Total Shareholder Return
3.74%3.74%-7.54%-138.30%-38.39%-893.01%
Updated Mar 9, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q